KRYS: Krystal Biotech Inc insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Institutional ownership (Q2 2026)
424 institutions reported holding $10.62B of Krystal Biotech Inc on Form 13F (369 the quarter before). 88 opened a new position and 36 sold out. Shares held by institutions: +7%.
| Largest holders | Shares | Value |
|---|---|---|
| FMR LLC | 4,418,197 | $1.64B |
| BlackRock, Inc. | 4,181,432 | $1.55B |
| Avoro Capital Advisors LLC | 2,888,888 | $1.07B |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,574,905 | $585.34M |
| STATE STREET CORP | 1,351,158 | $502.20M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,240,567 | $461.08M |
| Soleus Capital Management, L.P. | 939,254 | $349.09M |
| Capital World Investors | 777,843 | $289.10M |
| GEODE CAPITAL MANAGEMENT, LLC | 698,993 | $259.84M |
| Hood River Capital Management LLC | 663,375 | $246.56M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.